Status:
COMPLETED
Placenta Accreta Spectrum Disorder Conservative Managment Versus Hysterectomy Prospective Analysis
Lead Sponsor:
Nourhan Elsadany
Conditions:
Placenta Accreta
Eligibility:
FEMALE
18-40 years
Brief Summary
The aim of this study is to identify risk factors associated with performing cesarean hysterectomy versus conservative management in patients with placenta accreta spectrum (PAS). Research question W...
Detailed Description
Placenta accreta spectrum disorder (PAS) is a serious obstetric disorder that is characterized by low lying and deep penetration of the villi which are abnormally attached to the myometrium of the ute...
Eligibility Criteria
Inclusion
- Pregnant women with history of previous cesarean section.
- Age above 18 years.
- Gestational age above 28 weeks.
- Confirmed diagnosis of Placenta previa accreta spectrum disorder by U/S or MRI if needed.
- U/S signs suggestive of placenta previa accrete (Green-top Guideline).
Exclusion
- Gestational age less than 28 weeks.
- Age less than 18years
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06105034
Start Date
March 1 2022
End Date
September 1 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nourhan Abdelhady Soliman Elsadany
Giza, Egypt, 267138